Beanlic
Published by:
National Comprehensive Cancer Network
Description
The oncology reimbursement landscape continues to present ever-evolving challenges for clinicians and others who work with patients with cancer. As a response to these ongoing challenges, help is available through the NCCN Reimbursement Resource App.
Users can select a cancer or supportive care indication, search by drug name, or select a reimbursement or assistance program to learn about available reimbursement help and services to help mitigate reimbursement challenges.
Hide
Show More...
Users can select a cancer or supportive care indication, search by drug name, or select a reimbursement or assistance program to learn about available reimbursement help and services to help mitigate reimbursement challenges.
Screenshots
Beanlic FAQ
-
Is Beanlic free?
Yes, Beanlic is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is Beanlic legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does Beanlic cost?
Beanlic is free.
-
What is Beanlic revenue?
To get estimated revenue of Beanlic app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Portugal yet.
Ratings History
Beanlic Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
NCCN Reimbursement Resource Installs
Last 30 days
NCCN Reimbursement Resource Revenue
Last 30 daysBeanlic Revenue and Downloads
Gain valuable insights into NCCN Reimbursement Resource performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- National Comprehensive Cancer Network
- Languages
- Recent release
- 2.3.1 (5 years ago )
- Released on
- May 29, 2014 (11 years ago )
- Also available in
- United States, Germany, Israel, Philippines, Ecuador, Vietnam, Australia, South Korea, Canada, China, Hungary, Kuwait, Kazakhstan, Lebanon, Mexico, Russia, South Africa, Japan, Malaysia, India, Italy, Egypt, Spain, Hong Kong SAR China, Belgium, Brazil, Austria, Dominican Republic, Colombia, Romania, Azerbaijan, Indonesia, Ireland, Nigeria, Türkiye, Saudi Arabia, Czechia, Chile, Belarus, Portugal, New Zealand, United Arab Emirates, Argentina, Poland, Taiwan, Greece, Thailand, Pakistan, Norway, Peru, France, Sweden, Ukraine, Singapore
- Last Updated
- 3 months ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.